By: Donald Trump, Dave Ramsey, Sarah Horvath, Thomas Hughes, Gabriel Osorio-Mazilli, Ryan Hasson, Warren Buffett
Omega Therapeutics ( NASDAQ:OMGA - Get Free Report ) had its target price dropped by stock analysts at Chardan Capital from $7.00 to $6.00 in a report released on Wednesday, Benzinga reports.